Taka Kubo has left Canal Ventures to join medical data startup Yuimedi.

After five years at Japanese IT services company Biprogy, Taka Kubo is trading investment for operations as he joins Yuimedi – a Japanese startup focused on healthcare data intelligence – as head of strategy.  

“While I have developed my career as an investor for half a decade, I haven’t had a true experience of startup and starting a business from zero,” Kubo tells GCV.  

“This notion stuck in my head for a long time and gradually became more complex for me as an investor. Therefore, I made my choice to change my path to join Yuimedi.”

After starting his career at Biprogy, he rejoined the company in 2021, opening its office in Boston and focused on scouting new technology, before joining its corporate VC, Canal Ventures, in 2023 and becoming its managing director and vice chief strategy officer.

Kubo was an investor at VC firm Scrum Ventures between 2019 and 2021, prior to which he spent nine years at Nihon Unisys, which later rebranded to Biprogy.

Fernando Moncada Rivera

Fernando Moncada Rivera is a reporter at Global Corporate Venturing and also host of the CVC Unplugged podcast.